Gregory Collier

Gregory Collier

Health Technology
Consumer Services
Distribution Services

Profil

Dr. Gregory Collier is an Executive Chairman at Prevatex Pty Ltd., a Chairman at Tessara Therapeutics Pty Ltd. and a Non-Executive Chairman at Avecho Biotechnology Ltd. Dr. Collier was previously employed as a Chief Executive Officer by Invion Ltd., a Chief Executive Officer & Managing Director by ChemGenex Pharmaceuticals, Inc., a Professor by Deakin University, a Principal by Monash University, a Non-Executive Director by Photonz Corp.
Ltd., a Principal by University of Melbourne, and a Principal by University of Toronto.
He also served on the board at Gemini Biotechnology, Barwon Biotechnology Pty Ltd., Fusion Biosciences Pty Ltd. and VITALITY Devices Pty Ltd. He received his undergraduate degree from the University of Melbourne and a doctorate degree from Monash University.

Aktive Positionen von Gregory Collier

UnternehmenPositionBeginn
AVECHO BIOTECHNOLOGY LIMITED Vorsitzender 01.01.2019
Gründer 01.01.2020
Vorsitzender 01.10.2019

Ehemalige bekannte Positionen von Gregory Collier

UnternehmenPositionEnde
Gemini Biotechnology
Gründer 01.01.2022
INVION LIMITED Vorstandsvorsitzender 31.10.2019
Fusion Biosciences Pty Ltd.
Direktor/Vorstandsmitglied -
Barwon Biotechnology Pty Ltd.
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Sehen Sie sich die Erfahrung von Gregory Collier im Detail an

Ausbildung von Gregory Collier

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

30

Beziehungen ersten Grades

14

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen14

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Gemini Biotechnology

Distribution Services

Barwon Biotechnology Pty Ltd.

Fusion Biosciences Pty Ltd.

Technology Services

Health Technology

  1. Börse
  2. Insiders
  3. Gregory Collier